Metal-removing therapy may help some heart patients-study
November 5th, 2012
By Deena Beasley and Bill Berkrot LOS ANGELES | Sun Nov 4, 2012 7:36pm EST LOS ANGELES (Reuters) – A controversial therapy to remove heavy metals from the bloodstream was shown in a large trial to cut the risk of another major heart problem in patients who have already suffered a heart attack, but researchers cautioned that the benefit was small and more study is needed. Chelation therapy, an alternative treatment dismissed by many medical professionals as quackery, has its origins in unproven 50-year-old theories about the cause of arterial plaques, the fatty deposits that can cause heart attacks.
[Continue Reading...]
Sanofi considered moving headquarters abroad: report
November 4th, 2012
PARIS | Sun Nov 4, 2012 11:04am EST PARIS (Reuters) – Sanofi’s management considered moving its headquarters abroad in the last few months but the plan was nixed by the drugmaker’s chairman, French weekly Le Journal du Dimanche reported on Sunday, citing sources close to the board. First mooted in July, when the Socialist government was preparing to introduce a 75 percent tax on top earnings, the plan envisaged moving the headquarters to London or the United States, or at least relocating Chief Executive Chris Viehbacher and his closest associates abroad
[Continue Reading...]
Israel’s Neuronix offers new Alzheimer’s treatment
November 4th, 2012
By Tova Cohen TEL AVIV | Sun Nov 4, 2012 4:35am EST TEL AVIV (Reuters) – Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer’s disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014.
[Continue Reading...]
Ivermectin hair lotion found effective against lice
October 31st, 2012
By Gene Emery NEW YORK | Wed Oct 31, 2012 6:05pm EDT NEW YORK (Reuters Health) – A single 10-minute hair application of a drug used in oral form since the 1980s to control river blindness and other parasitic diseases eliminated head lice in nearly three of four children in a new study. The lotion contains ivermectin and is sold under the brand name Sklice by Sanofi Pasteur, which paid for the study. The U.S
[Continue Reading...]
Top medical innovations treat headaches, diabetes
October 31st, 2012
An Autonomic Technologies Inc. (ATI) Neurostimulator, an almond-size device that is implanted in the mouth to relief severe headaches, is pictured in this undated handout photo. The best medical innovations for next year include the device and a hand-held scanner resembling a blow dryer that detects skin cancer, the Cleveland Clinic said on October 31, 2012
[Continue Reading...]
GSK raises bet on AIDS drug with new Shionogi deal
October 29th, 2012
Signage is pictured on the company headquarters of GlaxoSmithKline in west London July 21, 2008. GlaxoSmithKline announce their half yearly results on Wednesday July 23. Credit: Reuters/Toby Melville By Ben Hirschler and Mayumi Negishi LONDON/TOKYO | Mon Oct 29, 2012 7:03am EDT LONDON/TOKYO (Reuters) – GlaxoSmithKline has raised its bet on a promising drug for HIV/AIDS by redrawing a deal with Japan’s Shionogi which gives it a much bigger economic interest in the new product
[Continue Reading...]
Landmark Medicare settlement could change lives
October 27th, 2012
U.S. Health and Human Services Secretary Kathleen Sebelius and the FDA’s Margaret Hamburg announce new tobacco package labelling, in the Brady Press Briefing Room of the White House in Washington, June 21, 2011. Credit: Reuters/Jason Reed By Mark Miller CHICAGO | Sat Oct 27, 2012 2:56pm EDT CHICAGO (Reuters) – Glenda Jimmo has had a challenging life.
[Continue Reading...]
Report casts doubt on medical guidelines
October 24th, 2012
By Frederik Joelving NEW YORK | Wed Oct 24, 2012 10:39am EDT NEW YORK (Reuters Health) – Many medical guidelines don’t stick to quality standards designed to make them trustworthy, and the situation hasn’t improved over the past two decades, researchers have found. “Everybody everywhere is developing guidelines and there is no real quality control,” said Dr.
[Continue Reading...]
Israeli medical device offers new Alzheimer’s treatment
October 24th, 2012
By Tova Cohen TEL AVIV | Wed Oct 24, 2012 8:06am EDT TEL AVIV (Reuters) – Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer’s disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014
[Continue Reading...]
